Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 3/20 | 1.00 |
| ▸ | F3 | P13726 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 1.00 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | ECE1 | P42892 | 1/20 | 1.00 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 1.00 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 1.00 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | BID | P55957 | 7/20 | 0.95 |
| ▸ | MCL1 | Q07820 | 7/20 | 0.95 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 0.95 |
| ▸ | BAK1 | Q16611 | 6/20 | 0.95 |
| ▸ | KAT8 | Q9H7Z6 | 4/20 | 0.84 |
| ▸ | EP300 | Q09472 | 3/20 | 0.84 |
| ▸ | KAT5 | Q92993 | 3/20 | 0.84 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5370295 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL5394786 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL5370300 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Ginkgolic Acid 17:1 SCHEMBL5380765 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL13311658 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Gingkolic Acid SCHEMBL163525 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Ginkgolic Acid 17:1 SCHEMBL5380775 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Gingkolic Acid SCHEMBL8040660 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL5370293 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Gingkolic Acid SCHEMBL8042802 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116376936-A | Method for biosynthesis of ginkgolic acid and gene sequence thereof | 青岛农业大学 | 2023-07-04 | — | — | CN | claimed |
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | claimed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | claimed |
| CN-116376936-A | Method for biosynthesis of ginkgolic acid and gene sequence thereof | 青岛农业大学 | 2023-07-04 | — | — | CN | disclosed |
| US-20200237698-A1 | Viral Inhibitor | RUSH UNIVERSITY MEDICAL CENTER (US) | 2020-07-30 | — | — | US | disclosed |
| US-9149019-B2 | Method of eliminating cat urine odor | JMR, LC (US) | 2015-10-06 | — | — | US | disclosed |
| US-20130323194-A1 | METHOD OF ELIMINATING CAT URINE ODOR | CO2 TECHNOLOGIES, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |
| US-20070066170-A1 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2007-03-22 | — | — | US | disclosed |
| US-7189666-B2 | CO2 generating absorbent pads | CO2 TECHNOLOGIES (US) | 2007-03-13 | — | — | US | disclosed |
| US-7160939-B2 | Preservatives; mixture of carbon dioxide in polymer matrix; mixture containing citric acid, calcium carbonate and low density polyethylene | CO2 TECHNOLOGIES, INC. | 2007-01-09 | — | — | US | disclosed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | disclosed |
| WO-2005005520-A2 | ACTIVE MASTERBATCH FOR PRODUCTION OF CO2 GENERATING MASTERBATCH | CO2 TECHNOLOGIES, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| US-20050001204-A1 | Active masterbatch for production of CO2 generating masterbatch | CO2 TECHNOLOGIES, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| WO-2004110876-A2 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040247750-A1 | CO2 generating absorbent pads | CO2 TECHNOLOGIES, INC. | 2004-12-09 | — | — | US | disclosed |
| US-6797235-B2 | Device and methods for modifying an atmosphere | CO2 TECHNOLOGIES, INC. | 2004-09-28 | — | — | US | disclosed |
| WO-2004022112-A1 | DEVICE AND METHODS FOR MODIFYING AN ATMOSPHERE | CO2 TECHNOLOGIES, INC. (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20040047760-A1 | Device and methods for modifying an atmosphere | LONGER SHELF LIFE, LLC | 2004-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200237698-A1 | Viral Inhibitor | HAVCR2, SERPINB1, EIF2AK2 | F7 1538/4885F3 2131/4885MMP2 468/4885 |
| US-20060111582-A1 | Process for arylamine production | AOC2, UFM1, TYR | F7 2687/4885F3 1463/4885MMP2 3630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.